What does Abbott India do?
Abbott India Ltd. is a leading multinational pharmaceutical company in India, with recent net sales of ₹16,046 Cr and a net profit of ₹3,670 Cr as of March 2025. It has a market cap of ₹73,197 Cr and key metrics include a P/E ratio of 51.00 and a dividend yield of 1.19%.
Overview: Abbott India Ltd. is a leading multinational pharmaceutical company in India, categorized as a Large Cap in the Pharmaceuticals & Biotechnology industry.History:
Abbott India Ltd. was incorporated in an unspecified year and has maintained its status as a prominent player in the pharmaceutical sector. The latest quarterly results reported net sales and net profit for the period ending March 2025.
Financial Snapshot:
- Most recent Net Sales: 16,046 Cr (Quarterly Results - Mar 2025)
- Most recent Net Profit: 3,670 Cr (Quarterly Results - Mar 2025)
- Market-cap value: INR 73,197 Cr (Large Cap)
Key Metrics:
- P/E: 51.00
- Industry P/E: 37
- Dividend Yield: 1.19%
- Debt-Equity: -0.30
- Return on Equity: 40.17%
- Price to Book: 20.72
Contact Details:
Address: Unit No 3 Corporate Park, Sion Trombay Road Chembur Mumbai Maharashtra : 400071
Tel: 91-22-67978888/50461000/2000/1119
Email: investorrelations.india@abbott.com
Website: http://www.abbott.co.in
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
